Patient
SITE014-0280
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE014 (NLD) (Dr. Moreau)
consented 2026-08-03
Adverse events
1
Serious AEs
0
Open data queries
1
Luna dropout signal
—
not on Luna
Adverse events 1
moderate
assessed
2026-08-19
Grade 2 Diarrhoea — outcome: UNKNOWN; onset 2023-02-12 (study day 2); relationship: NOT RELATED
Data queries 1
onset_on[Diarrhoea 2026-08-19]
open
AE Diarrhoea (grade 2) for SITE014-0280 has onset 2026-08-19, 1 d before first dose on 2026-08-20. Confirm onset date or record as pre-treatment.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.